adesso Salute del bilancio
Criteri Salute finanziaria verificati 5/6
adesso ha un patrimonio netto totale di €196.3M e un debito totale di €195.7M, che porta il suo rapporto debito/patrimonio netto a 99.7%. Le sue attività totali e le sue passività totali sono rispettivamente €892.8M e €696.4M. L'EBIT di adesso è €62.4M rendendo il suo rapporto di copertura degli interessi 5.3. Ha liquidità e investimenti a breve termine pari a €57.7M.
Informazioni chiave
99.69%
Rapporto debito/patrimonio netto
€195.72m
Debito
| Indice di copertura degli interessi | 5.3x |
| Contanti | €57.73m |
| Patrimonio netto | €196.34m |
| Totale passività | €696.45m |
| Totale attività | €892.78m |
Aggiornamenti recenti sulla salute finanziaria
Articolo di analisi • Jan 22
adesso (ETR:ADN1) Seems To Use Debt Quite Sensibly
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Articolo di analisi • Nov 02
Does adesso (ETR:ADN1) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Articolo di analisi • Oct 11
Does adesso (ETR:ADN1) Have A Healthy Balance Sheet?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Articolo di analisi • Feb 11
adesso (ETR:ADN1) Has A Pretty Healthy Balance Sheet
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Recent updates
Aggiornamento della narrazione • May 09
ADN1: 2026 Earnings Guidance And Dividend Policy Will Support Future Upside Potential
Analysts have reduced their price target on adesso from €114.17 to €107.67, citing slightly revised revenue growth and P/E assumptions along with a modestly higher profit margin outlook. What's in the News adesso reaffirmed earnings guidance for 2026, with expected revenues in a range of €1.6b to €1.7b and guidance that EBIT margin is expected to show only a little improvement in 2026 (Corporate Guidance).
Aggiornamento della narrazione • Apr 24
ADN1: Higher Discount Rate Will Create Long Term Opportunity
Analysts have reduced their price target on adesso from €160 to €140, citing updated assumptions for a higher discount rate, slightly lower revenue growth and profit margin expectations, and a higher future P/E multiple. What's in the News adesso SE reaffirmed earnings guidance for 2026, with expected revenues in a range between €1.6b and €1.7b and only a little improvement in the EBIT margin in that year (Corporate Guidance).Aggiornamento della narrazione • Apr 10
ADN1: Dividend Visibility And Expanded Partnership Will Support Future Upside Potential
Analysts have trimmed their price target for adesso from about €127.83 to about €114.17. They now apply a higher discount rate, slightly lower revenue growth and profit margin assumptions, and a higher future P/E multiple in their models.Articolo di analisi • Apr 07
Shareholders Can Be Confident That adesso's (ETR:ADN1) Earnings Are High Quality
When companies post strong earnings, the stock generally performs well, just like adesso SE's ( ETR:ADN1 ) stock has...Articolo di analisi • Feb 12
The Price Is Right For adesso SE (ETR:ADN1) Even After Diving 28%
The adesso SE ( ETR:ADN1 ) share price has fared very poorly over the last month, falling by a substantial 28%. Instead...Articolo di analisi • Jan 22
adesso (ETR:ADN1) Seems To Use Debt Quite Sensibly
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Articolo di analisi • Oct 19
Is There Now An Opportunity In adesso SE (ETR:ADN1)?
adesso SE ( ETR:ADN1 ), is not the largest company out there, but it saw a significant share price rise of 23% in the...Articolo di analisi • Sep 12
A Piece Of The Puzzle Missing From adesso SE's (ETR:ADN1) 32% Share Price Climb
adesso SE ( ETR:ADN1 ) shareholders would be excited to see that the share price has had a great month, posting a 32...Articolo di analisi • Sep 10
Here's What's Concerning About adesso's (ETR:ADN1) Returns On Capital
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Articolo di analisi • May 25
Solid Earnings Reflect adesso's (ETR:ADN1) Strength As A Business
adesso SE's ( ETR:ADN1 ) earnings announcement last week was disappointing for investors, despite the decent profit...Articolo di analisi • Feb 25
adesso (ETR:ADN1) Has Announced That It Will Be Increasing Its Dividend To €0.75
The board of adesso SE ( ETR:ADN1 ) has announced that the dividend on 6th of June will be increased to €0.75, which...
Nuova narrazione • Feb 07
Ongoing IT Investments Will Transform Operations By Mid-2025
Organic growth in healthcare and utilities drives future revenue, overcoming economic challenges, while strategic share buybacks reflect belief in undervaluation.Articolo di analisi • Dec 02
Investors Still Aren't Entirely Convinced By adesso SE's (ETR:ADN1) Revenues Despite 32% Price Jump
adesso SE ( ETR:ADN1 ) shares have continued their recent momentum with a 32% gain in the last month alone. Not all...Articolo di analisi • Nov 22
adesso (ETR:ADN1) Is Posting Promising Earnings But The Good News Doesn’t Stop There
Investors signalled that they were pleased with adesso SE's ( ETR:ADN1 ) most recent earnings report. Looking deeper at...Articolo di analisi • Nov 17
adesso SE (ETR:ADN1) Just Reported, And Analysts Assigned A €122 Price Target
The investors in adesso SE 's ( ETR:ADN1 ) will be rubbing their hands together with glee today, after the share price...Articolo di analisi • Nov 02
Does adesso (ETR:ADN1) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Articolo di analisi • Aug 28
It's Down 25% But adesso SE (ETR:ADN1) Could Be Riskier Than It Looks
The adesso SE ( ETR:ADN1 ) share price has fared very poorly over the last month, falling by a substantial 25%. Instead...Articolo di analisi • May 21
adesso's (ETR:ADN1) Shareholders Will Receive A Bigger Dividend Than Last Year
The board of adesso SE ( ETR:ADN1 ) has announced that it will be paying its dividend of €0.70 on the 7th of June, an...Articolo di analisi • Apr 19
adesso (ETR:ADN1) Has Announced That It Will Be Increasing Its Dividend To €0.70
The board of adesso SE ( ETR:ADN1 ) has announced that it will be paying its dividend of €0.70 on the 7th of June, an...Articolo di analisi • Apr 18
Returns On Capital Signal Tricky Times Ahead For adesso (ETR:ADN1)
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...Articolo di analisi • Apr 02
Investors Can Find Comfort In adesso's (ETR:ADN1) Earnings Quality
The market for adesso SE's ( ETR:ADN1 ) shares didn't move much after it posted weak earnings recently. We did some...Articolo di analisi • Mar 28
Analysts Are Updating Their adesso SE (ETR:ADN1) Estimates After Its Annual Results
Last week saw the newest full-year earnings release from adesso SE ( ETR:ADN1 ), an important milestone in the...Articolo di analisi • Mar 23
Is adesso SE (ETR:ADN1) Trading At A 44% Discount?
Key Insights adesso's estimated fair value is €193 based on 2 Stage Free Cash Flow to Equity Current share price of...Articolo di analisi • Mar 08
adesso SE (ETR:ADN1) Soars 29% But It's A Story Of Risk Vs Reward
adesso SE ( ETR:ADN1 ) shares have had a really impressive month, gaining 29% after a shaky period beforehand. Not all...Articolo di analisi • Dec 14
A Look At The Intrinsic Value Of adesso SE (ETR:ADN1)
Key Insights Using the 2 Stage Free Cash Flow to Equity, adesso fair value estimate is €95.16 With €91.00 share price...Articolo di analisi • Oct 11
Does adesso (ETR:ADN1) Have A Healthy Balance Sheet?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Articolo di analisi • Jul 22
At €106, Is It Time To Put adesso SE (ETR:ADN1) On Your Watch List?
adesso SE ( ETR:ADN1 ), might not be a large cap stock, but it received a lot of attention from a substantial price...Articolo di analisi • Jun 15
Calculating The Intrinsic Value Of adesso SE (ETR:ADN1)
Key Insights Using the 2 Stage Free Cash Flow to Equity, adesso fair value estimate is €146 With €123 share price...Articolo di analisi • May 09
adesso's (ETR:ADN1) Returns On Capital Not Reflecting Well On The Business
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...Articolo di analisi • Apr 22
What Does adesso SE's (ETR:ADN1) Share Price Indicate?
While adesso SE ( ETR:ADN1 ) might not be the most widely known stock at the moment, it saw significant share price...Articolo di analisi • Feb 11
adesso (ETR:ADN1) Has A Pretty Healthy Balance Sheet
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Articolo di analisi • Jan 26
Returns On Capital At adesso (ETR:ADN1) Have Stalled
If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...Articolo di analisi • Jan 10
Calculating The Fair Value Of adesso SE (ETR:ADN1)
How far off is adesso SE ( ETR:ADN1 ) from its intrinsic value? Using the most recent financial data, we'll take a look...Analisi della posizione finanziaria
Passività a breve termine: Le attività a breve termine ( €442.5M ) di ADN1 superano le sue passività a breve termine ( €348.1M ).
Passività a lungo termine: Le attività a breve termine di ADN1 ( €442.5M ) superano le sue passività a lungo termine ( €348.3M ).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: Il rapporto debito netto/patrimonio netto ( 70.3% ) di ADN1 è considerato alto.
Riduzione del debito: Il rapporto debito/patrimonio netto di ADN1 si è ridotto da 138% a 99.7% negli ultimi 5 anni.
Copertura del debito: Il debito di ADN1 è ben coperto dal flusso di cassa operativo ( 42.4% ).
Copertura degli interessi: I pagamenti degli interessi sul debito di ADN1 sono ben coperti dall'EBIT ( 5.3 x copertura).
Bilancio
Scoprire le aziende sane
Analisi aziendale e situazione dei dati finanziari
| Dati | Ultimo aggiornamento (ora UTC) |
|---|---|
| Analisi dell'azienda | 2026/05/20 04:37 |
| Prezzo dell'azione a fine giornata | 2026/05/20 00:00 |
| Utili | 2026/03/31 |
| Utili annuali | 2025/12/31 |
Fonti dei dati
I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
| Pacchetto | Dati | Tempistica | Esempio Fonte USA * |
|---|---|---|---|
| Dati finanziari della società | 10 anni |
| |
| Stime di consenso degli analisti | +3 anni |
|
|
| Prezzi di mercato | 30 anni |
| |
| Proprietà | 10 anni |
| |
| Gestione | 10 anni |
| |
| Sviluppi principali | 10 anni |
|
* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.
Modello di analisi e Snowflake
I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.
Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali
Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.
Fonti analitiche
adesso SE è coperta da 11 analisti. 6 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
| Analista | Istituzione |
|---|---|
| Daniel Großjohann | BankM AG |
| Wolfgang Specht | Berenberg |
| Finn Kemper | Hauck Aufhäuser Investment Banking |